December 1, 2021 – Merck Pill Gets FDA Panel Support, Latest On Omicron & More episode artwork

EPISODE · Dec 1, 2021 · 22 MIN

December 1, 2021 – Merck Pill Gets FDA Panel Support, Latest On Omicron & More

from COVID in L.A. · host LAist Studios

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Peter Chin-Hong, infectious disease specialist and professor of medicine at the UCSF Medical Center.  Topics today include:  Merck pill gets FDA panel support in a 13-10 vote.  Biden administration expected to toughen testing requirements for international travelers.  Omicron likely had began to spread from South Africa prior to it being detected.  Los Angeles County has no significant plans for new COVID-19 restrictions.  If vaccines prove to be ineffective, county health department’s first priority will be protecting nursing homes.  Bay Area Scientist explains Omicron variant’s set of mutations.  California patient confirmed to have first US case of the Omicron variant.  This program is made possible in part by the Corporation for Public Broadcasting, a private corporation funded by the American people.

Episode metadata supplied by the publisher feed · Published Dec 1, 2021

Embed this episode

NOW PLAYING

December 1, 2021 – Merck Pill Gets FDA Panel Support, Latest On Omicron & More

0:00 22:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of COVID in L.A.?

This episode is 22 minutes long.

When was this COVID in L.A. episode published?

This episode was published on December 1, 2021.

Can I download this COVID in L.A. episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!